Aldosterone
GET
/api/v1/drug/aldosteroneIndications
Sourced from openFDA- HOMEOPATHIC INDICATIONS: Temporary relief of symptoms related to hormone imbalances of insufficiencies in men and women, including low energy, inability to handle stress, trouble focusing, changes in mood, infertility, irregular menstrual cycles (females), and lack of libido.** **These statements are based upon homeopathic principles. They have not been reviewed by the Food and Drug Administration.
Dosage & administration
Sourced from openFDADIRECTIONS: 1-10 drops under the tongue, 3 times a day or as directed by your health professional. Consult a physician for use in children under 12 years of age.
Warnings & precautions
Sourced from openFDAKeep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. If pregnant or breast-feeding, ask a healthcare professional before use. Tamper seal: sealed for your protection. Do not use if seal is broken or missing.
FAERS reports
Reference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. Counts reflect reporting volume — how often a reaction was reported, not how often it occurs. For decision-grade use, consult openFDA and the FAERS Public Dashboard directly.
2 total reports matchedLatest report Share = reports listing the reaction ÷ total matched reports. Rows can sum to >100% because a single report often lists multiple reactions.
- 1Chills150%
- 2Dizziness150%
- 3Fatigue150%
- 4Headache150%
- 5Hyperhidrosis150%
- 6Incorrect Dose Administered150%
- 7Nausea150%
- 8Pyrexia150%
- 9Wrong Technique In Device Usage Process150%
Literature
Recent PubMed references pinned to Aldosterone as a MeSH major topic. Citations link to pubmed.ncbi.nlm.nih.gov.
- Esaxerenone Attenuates Aldosterone-Induced Renal Fibrosis by Suppressing Fibroblast-to-Lymphatic Endothelial-like Cell Transdifferentiation.International journal of molecular sciences · 2026 · Wang J, Yang S, Wang X, et al.PMID 42196278DOI 10.3390/ijms27104297
- An unexpected finding of apparent bilateral aldosterone suppression after superselective adrenal venous sampling: a case report.Blood pressure · 2026 · Pan X, Ma Y, Kang Y, et al.PMID 42165404DOI 10.1080/08037051.2026.2678033
- The diagnostic value of 68Ga-pentixafor PET/CT in differentiating adrenal aldosterone-producing adenomas from non-functional adenomas.Endocrine-related cancer · 2026 · Cheng S, Kuang Y, Zhang X, et al.PMID 42160367DOI 10.1530/ERC-25-0371
- Roflumilast Enhances Liraglutide's Atrial Natriuretic Peptide-Dependent Suppression of Adrenal Aldosterone Secretion.International journal of molecular sciences · 2026 · Hosseini A, M'Sadoques AJ, Stoicovy RA, et al.PMID 42123676DOI 10.3390/ijms27094098
- Association between aldosterone and the risk of cardiovascular disease in hypertensive patients: a cohort study.Frontiers in endocrinology · 2026 · Gan L, Li N, Heizhati M, et al.PMID 42109741DOI 10.3389/fendo.2026.1791569
- TPD52 inhibits aldosterone synthesis through suppression of CAMKK2 signaling.European journal of endocrinology · 2026 · Xie L, Ma L, Kang B, et al.PMID 42065138DOI 10.1093/ejendo/lvag073
- Multicentre evidence for an independent association between third-trimester hypoaldosteronism and preeclampsia.Scientific reports · 2026 · Yang M, Wang M, Zhu Q, et al.PMID 41975049DOI 10.1038/s41598-026-48499-y
- Gut microbiota signatures in primary aldosteronism and functional identification of an aldosterone-degrading gut bacterium.Gut microbes · 2026 · Zhang Z, Chen C, Zhang M, et al.PMID 41964107DOI 10.1080/19490976.2026.2657047
Clinical trials
The 10 most recently updated of 375 ClinicalTrials.gov registrations naming Aldosterone as an intervention. Registration is not evidence of efficacy or safety — reference crosswalk only.
- A Phase II Clinical Trial of Efficacy and Safety of SAL0140 at Different Doses in Patients With Primary AldosteronismNot yet recruiting · Phase 2 · Interventional · 50 enrolled · Shenzhen Salubris Pharmaceuticals Co., Ltd.NCT07646535updated 2026-06-12
- Radiofrequency Ablation Versus Adrenalectomy for Adenoma in Patients With Primary Aldosteronism and HypertensionRecruiting · Interventional · 134 enrolled · University Hospital, ToulouseNCT07470580updated 2026-06-11
- EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)Recruiting · Phase 3 · Interventional · 11,000 enrolled · Boehringer IngelheimNCT06531824updated 2026-06-11
- Study on the Diagnostic Cut-off Point of 24-hour Urinary Aldosterone Measured by Liquid Chromatography-Tandem Mass Spectrometry in the Diagnosis of Primary Aldosteronism in the Oral Sodium Loading TestRecruiting · Observational · 800 enrolled · Peking Union Medical College HospitalNCT07635134updated 2026-06-09
- HEART: Pilot Randomized Controlled TrialRecruiting · Phase 1 · Phase 2 · Interventional · 50 enrolled · Mayo ClinicNCT07483177updated 2026-06-08
- Efficacy and Safety of Lorundrostat in Addition to Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2i) in Subjects With Hypertension and Chronic Kidney Disease (CKD) With AlbuminuriaCompleted · Phase 2 · Interventional · 60 enrolled · Mineralys Therapeutics Inc.NCT06150924updated 2026-06-03
- Study on Cutoff Revision Effects and Evaluation of NNT in Primary AldosteronismRecruiting · Observational · 150 enrolled · Seoul National University HospitalNCT07621458updated 2026-06-02
- Effects of Repletion of Sodium Chloride on Natriuresis, Blood Pressure, and Neurohormonal Activity in Patients With Chronic Heart Failure With Reduced Ejection FractionNot yet recruiting · Interventional · 30 enrolled · Wroclaw Medical UniversityNCT07614295updated 2026-05-29
- Comparative Study on the Mode of Action of Vicadrostat and Spironolactone on Protein Profiles and Renal Hemodynamic Effects (COMPARE-VS)Recruiting · Phase 2 · Interventional · 100 enrolled · University Medical Center GroningenNCT07304817updated 2026-05-29
- RAFT - Pace &AblateRecruiting · Interventional · 600 enrolled · Habib KhanNCT06299514updated 2026-05-26
Frequently asked questions
- What is Aldosterone used for?
- According to FDA labeling, Aldosterone carries indications including: HOMEOPATHIC INDICATIONS: Temporary relief of symptoms related to hormone imbalances of insufficiencies in men and women, including low energy, inability to handle stress, trouble focusing, changes in mood, infertility, irregular menstrual cycles (females), and lack of libido.** **These statements are based upon homeopathic principles. They have not been reviewed by the Food and Drug Administration.. This is a reference summary of labeled uses, not medical advice or a treatment recommendation.
- What class of drug is Aldosterone?
- Aldosterone is classified as Mineralocorticoids.
Note. Data for
aldosterone is illustrative MVP content compiled from public sources. pharmacopeia is for educational and informational use only and is not a substitute for professional medical advice.